SOFIE

SOFIE is a leading provider of molecular diagnostics and therapeutics, specialising in the development and delivery of radiopharmaceuticals to enhance patient outcomes.​

Established in 2008, SOFIE has grown into a prominent supplier within the pharmaceutical industry, focusing on positron emission tomography (PET) imaging and theranostics. The company's mission is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics). With a robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and high-value theranostic intellectual property, SOFIE is delivering on the promise of radiopharmaceuticals. ​

Key Products and Services:

Radiopharmaceuticals: SOFIE offers a diverse range of radiopharmaceuticals designed for PET imaging, which are used in the diagnosis and treatment of various critical illnesses. The company’s product portfolio includes innovative PET tracers such as [18F]FAPI-74, which is utilised in clinical trials and diagnostic procedures. SOFIE’s pipeline of next-generation radiopharmaceuticals aims to address unmet medical needs and improve the precision of molecular diagnostics. ​

Contract Manufacturing Services: SOFIE provides comprehensive contract manufacturing services, ensuring the reliable production and distribution of high-quality radiopharmaceuticals to its clients. This includes regulatory services, containment, injectables, clinical dose manufacturing, packaging, clinical packaging, and active pharmaceutical ingredients (APIs). ​

Radiopharmacy Network: With a network of 14 sites, SOFIE is committed to the timely delivery of radiopharmaceuticals, meeting clients' needs in diagnosing and treating critical illnesses daily. ​

PET Education: SOFIE has developed multifaceted educational programmes designed to strengthen the quality of PET programmes in medical practices, thereby enhancing patient care. ​

Through its unwavering commitment to innovation and quality, SOFIE continues to play a pivotal role in advancing molecular imaging and theranostics, ultimately striving to improve patient health worldwide.